AFP specificity for HCC surveillance is increased by mitigating liver injury among treated chronic hepatitis B patients with elevated AFP

Autor: Yuan, Guosheng, Zhou, Yuchen, Liu, Junwei, Hu, Chengguang, Huang, Huaping, Ren, Yanyu, Yu, Wenxuan, Guo, Yabin, Zhang, Yong-Yuan, Zhou, Yuanping
Rok vydání: 2018
Předmět:
Zdroj: International journal of clinical and experimental pathology. 12(4)
ISSN: 1936-2625
Popis: Objective: The aim of this study was to assess AFP response in chronic hepatitis B (CHB) patients with baseline positive AFP (≥7 ng/mL) who received antiviral therapy thereafter. Methods: A cohort study was conducted to assess AFP response in CHB patients who had baseline positive AFP and got antiviral therapy. Results: This retrospective study enrolled 302 antiviral-treatment-naïve CHB patients with positive AFP. After a 12-month antiviral treatment, 144 patients normalized AFP during follow-up while the rest remained AFP-positive. There were no significant differences in baseline characteristics and virologic and ALT responses to antiviral therapy between the two groups. During a mean follow-up of 34 ± 6 months, 16 patients (5.3%) in this cohort developed HCC, and 14 (8.9%) of them emerged in the AFP positive group. There was a significant difference (P=0.004) in HCC occurrence between AFP normalized and non-normalized groups after treatment. Univariate and multivariate analyses revealed that cirrhosis (HR=9.983, 95% CI=3.609-27.617, P
Databáze: OpenAIRE